Yeast hydrolysate protects cartilage via stimulation of type II collagen synthesis and suppression of MMP-13 production

Hyun Sun Lee, So Yeon Park, Yooheon Park, Song Hwan Bae, Hyung Joo Suh

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Type II collagen (COL II) is one of the primary components of hyaline cartilage and plays a key role in maintaining chondrocyte function. COL II is the principal target of destruction, and matrix metalloproteases (MMPs) have a major role in arthritis. In the present study, we investigated the chondroctye protection effects of specific fraction of yeast hydrolysate ((10-30 kDa molecular weight peptides). The mRNA expression of COL II was significantly increased in the YH-treated group compared to the control at concentrations above 50 μg/ml, respectively. The 200 μg/ml YH-treated group (3.43 ± 0.23 μg/ml) showed significantly reduced glycosaminoglycan (GAG) degradation relative to that in the interleukin-1β (IL-1β)-treated control group (4.72 ± 0.05 μg/ml). In the YH-treated group, MMP-13 level was significantly decreased in a dose-dependent manner compared to the IL-1β-treated group without YH treatment. However, MMP-1 and MMP-3 level were not different from that of control. Under the same conditions, we also examined mRNA levels of COL II. The mRNA expression of COL II was significantly higher in the YH-treated group than in the IL-1β-treated control group at concentrations above 100 μg/ml. In conclusion, YH stimulated COL II synthesis and significantly inhibited MMP-13 and GAG degradation caused by IL-1β treatment.

Original languageEnglish
Pages (from-to)1414-1418
Number of pages5
JournalPhytotherapy Research
Volume27
Issue number9
DOIs
Publication statusPublished - 2013 Sep 1

Fingerprint

Collagen Type II
Metalloproteases
Cartilage
Interleukin-1
Yeasts
Glycosaminoglycans
Messenger RNA
Hyaline Cartilage
Control Groups
Chondrocytes
Arthritis
Molecular Weight
Peptides

Keywords

  • arthritis
  • interleukin-1β
  • metalloproteases-13
  • rabbit chondrocyte
  • type II collagen
  • yeast hydrolysate

ASJC Scopus subject areas

  • Pharmacology

Cite this

Yeast hydrolysate protects cartilage via stimulation of type II collagen synthesis and suppression of MMP-13 production. / Lee, Hyun Sun; Park, So Yeon; Park, Yooheon; Bae, Song Hwan; Suh, Hyung Joo.

In: Phytotherapy Research, Vol. 27, No. 9, 01.09.2013, p. 1414-1418.

Research output: Contribution to journalArticle

Lee, Hyun Sun ; Park, So Yeon ; Park, Yooheon ; Bae, Song Hwan ; Suh, Hyung Joo. / Yeast hydrolysate protects cartilage via stimulation of type II collagen synthesis and suppression of MMP-13 production. In: Phytotherapy Research. 2013 ; Vol. 27, No. 9. pp. 1414-1418.
@article{3fc5969d0013451ab6cf70da9f1a942f,
title = "Yeast hydrolysate protects cartilage via stimulation of type II collagen synthesis and suppression of MMP-13 production",
abstract = "Type II collagen (COL II) is one of the primary components of hyaline cartilage and plays a key role in maintaining chondrocyte function. COL II is the principal target of destruction, and matrix metalloproteases (MMPs) have a major role in arthritis. In the present study, we investigated the chondroctye protection effects of specific fraction of yeast hydrolysate ((10-30 kDa molecular weight peptides). The mRNA expression of COL II was significantly increased in the YH-treated group compared to the control at concentrations above 50 μg/ml, respectively. The 200 μg/ml YH-treated group (3.43 ± 0.23 μg/ml) showed significantly reduced glycosaminoglycan (GAG) degradation relative to that in the interleukin-1β (IL-1β)-treated control group (4.72 ± 0.05 μg/ml). In the YH-treated group, MMP-13 level was significantly decreased in a dose-dependent manner compared to the IL-1β-treated group without YH treatment. However, MMP-1 and MMP-3 level were not different from that of control. Under the same conditions, we also examined mRNA levels of COL II. The mRNA expression of COL II was significantly higher in the YH-treated group than in the IL-1β-treated control group at concentrations above 100 μg/ml. In conclusion, YH stimulated COL II synthesis and significantly inhibited MMP-13 and GAG degradation caused by IL-1β treatment.",
keywords = "arthritis, interleukin-1β, metalloproteases-13, rabbit chondrocyte, type II collagen, yeast hydrolysate",
author = "Lee, {Hyun Sun} and Park, {So Yeon} and Yooheon Park and Bae, {Song Hwan} and Suh, {Hyung Joo}",
year = "2013",
month = "9",
day = "1",
doi = "10.1002/ptr.4857",
language = "English",
volume = "27",
pages = "1414--1418",
journal = "Phytotherapy Research",
issn = "0951-418X",
publisher = "John Wiley and Sons Ltd",
number = "9",

}

TY - JOUR

T1 - Yeast hydrolysate protects cartilage via stimulation of type II collagen synthesis and suppression of MMP-13 production

AU - Lee, Hyun Sun

AU - Park, So Yeon

AU - Park, Yooheon

AU - Bae, Song Hwan

AU - Suh, Hyung Joo

PY - 2013/9/1

Y1 - 2013/9/1

N2 - Type II collagen (COL II) is one of the primary components of hyaline cartilage and plays a key role in maintaining chondrocyte function. COL II is the principal target of destruction, and matrix metalloproteases (MMPs) have a major role in arthritis. In the present study, we investigated the chondroctye protection effects of specific fraction of yeast hydrolysate ((10-30 kDa molecular weight peptides). The mRNA expression of COL II was significantly increased in the YH-treated group compared to the control at concentrations above 50 μg/ml, respectively. The 200 μg/ml YH-treated group (3.43 ± 0.23 μg/ml) showed significantly reduced glycosaminoglycan (GAG) degradation relative to that in the interleukin-1β (IL-1β)-treated control group (4.72 ± 0.05 μg/ml). In the YH-treated group, MMP-13 level was significantly decreased in a dose-dependent manner compared to the IL-1β-treated group without YH treatment. However, MMP-1 and MMP-3 level were not different from that of control. Under the same conditions, we also examined mRNA levels of COL II. The mRNA expression of COL II was significantly higher in the YH-treated group than in the IL-1β-treated control group at concentrations above 100 μg/ml. In conclusion, YH stimulated COL II synthesis and significantly inhibited MMP-13 and GAG degradation caused by IL-1β treatment.

AB - Type II collagen (COL II) is one of the primary components of hyaline cartilage and plays a key role in maintaining chondrocyte function. COL II is the principal target of destruction, and matrix metalloproteases (MMPs) have a major role in arthritis. In the present study, we investigated the chondroctye protection effects of specific fraction of yeast hydrolysate ((10-30 kDa molecular weight peptides). The mRNA expression of COL II was significantly increased in the YH-treated group compared to the control at concentrations above 50 μg/ml, respectively. The 200 μg/ml YH-treated group (3.43 ± 0.23 μg/ml) showed significantly reduced glycosaminoglycan (GAG) degradation relative to that in the interleukin-1β (IL-1β)-treated control group (4.72 ± 0.05 μg/ml). In the YH-treated group, MMP-13 level was significantly decreased in a dose-dependent manner compared to the IL-1β-treated group without YH treatment. However, MMP-1 and MMP-3 level were not different from that of control. Under the same conditions, we also examined mRNA levels of COL II. The mRNA expression of COL II was significantly higher in the YH-treated group than in the IL-1β-treated control group at concentrations above 100 μg/ml. In conclusion, YH stimulated COL II synthesis and significantly inhibited MMP-13 and GAG degradation caused by IL-1β treatment.

KW - arthritis

KW - interleukin-1β

KW - metalloproteases-13

KW - rabbit chondrocyte

KW - type II collagen

KW - yeast hydrolysate

UR - http://www.scopus.com/inward/record.url?scp=84883743435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883743435&partnerID=8YFLogxK

U2 - 10.1002/ptr.4857

DO - 10.1002/ptr.4857

M3 - Article

C2 - 23070893

AN - SCOPUS:84883743435

VL - 27

SP - 1414

EP - 1418

JO - Phytotherapy Research

JF - Phytotherapy Research

SN - 0951-418X

IS - 9

ER -